Search

everythinglearnresearchcommunity

for

Search:↓

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Improving the environment and cell interactions is key for creating human hair in the lab.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

The environment around melanocyte stem cells is key for hair regeneration and color, with certain injuries affecting hair color and potential treatments for pigmentation disorders.

Insulin helps heal corneal wounds and nerves in diabetic mice by activating the Wnt signaling pathway.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Using special RNA to target a mutant gene fixed hair problems in mice.

Hair follicle regeneration is possible but challenging, especially in humans, due to the need for specific cells and a better understanding of how they signal growth.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

Scientists made working hair follicles using stem cells, helping future hair loss treatments.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A new therapy sped up wound healing and reduced scarring in diabetic rats.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

A new model for hair regeneration in mice was created in 2015, which is faster and less invasive than the old method, producing normal hairs in about 21 days.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Artificial hair implantation using scaffolds is possible and PHDPE is more biocompatible than ePTFE.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

FDG PET/CT scans can change cancer treatment plans for dogs.

Nanog gene boosts stem cells, helps hair growth, and may treat hair loss.